Activity- and affinity-based probes as research tools — design, development and applic.

webinar

Tue, 28 Apr 2020, 16:00 CEST (Berlin)

Prof. Dr. Martin D. Witte, University of Groningen, The Netherlands

Activity- and affinity-based probes as research tools — design, development and applic.

The discovery that proteins and/or protein families of interest can be labelled selectively with chemical reagents resulted in an active research field that aims to profile the amount and activity of (a subset of) proteins in a relevant setting. For this purpose, a diverse set of so-called activity- and affinity-based probes (ABPs) have been developed nowadays. The molecular structure of these probes generally consists of a recognition element, which generates selectivity for the protein of interest, a reactive group or warhead, which facilitates covalent binding of the probe to the protein, and a reporter group, which is used for read-out purposes. The activity-based protein profiling field has matured over the past decades and these research tools are nowadays employed in both fundamental and applied settings.

During this webinar, I will introduce the basics of activity- and affinity-based protein profiling. I will describe the general design approaches for ABPs, as well as their applications. In the second part of the webinar, I will discuss novel combinatorial approaches to prepare probes and I will demonstrate how chemical probes can be combined with nanoLC-MS/MS and docking studies to map the binding sites of small molecules.

Current news

category
Events
DrugSpace 2026 Symposium - The Path to Digital Chemistry
October 6, 2026 11:28 CEST
Where Medicinal and Computational Chemistry Come Together We are delighted to invite drug hunters, compound enthusiasts, and molecule designers back to the virtual DrugSpace Symposium. The fifth edition takes place on December 9, 2026, under the theme “The Path to Digital Chemistry,” and turns the spotlight on where computational and...
Read on
category
Events
BioSolveIT at the Enamine Drug Discovery Conference 2026 in Riga
September 23, 2026 16:21 CEST
The Enamine Drug Discovery Conference in Riga (Latvia) comes to a close today. Our CEO Dr. Christian Lemmen and our SVP Application Science Dr. Marcus Gastreich spent the past four days, 20 to 23 September 2026, at the Radisson Blu Latvija Conference & Spa Hotel, and they return with much...
Read on
VAST Just Got Bigger — The September 2026 Update
September 17, 2026 09:00 CEST
More compounds. More chemistry. More opportunities to discover your next active. This August, explore Enamine’s largest compound catalog with infiniSee xREAL as BioSolveIT’s Tool of the Month. XtalPi has expanded its VAST Chemical Space, giving you access to almost six billion virtual product molecules built from over 25,000 carefully selected...
Read on